Digital health funding held steady in the first half of 2025, with AI-focused startups capturing the majority of capital and driving rapid adoption among providers. The digital health space also saw ...

Rural hospitals are facing growing cybersecurity threats and digital demands but often lack the resources to respond — a gap ...

June has seen a slew of executive hires, promotions, exits and layoffs across the healthcare sector. For example, CVS Health ...

The Trump administration's healthcare policy changes from the gutting of medical research grants to changes on the CDC vaccine board were the focus of the discussion on the latest episode of the ...

First level of care The obvious concern is that no one should be encouraged to stay home and avoid seeking help if they are in imminent danger. So successful RPM tools must be built to provide a ...

Insmed reported that the low dose of brensocatib led to a 21.1% reduction in the rate of pulmonary exacerbations compared to placebo measured at 52 weeks; the high dose achieved a 19.4% reduction ...

By reimagining the payment experience through transparency, flexibility, and technology, providers can drive better outcomes for both their bottom line and the patients they serve.

The Supreme Court upheld the constitutionality of an Affordable Care Act provision requiring insurance coverage of certain preventive services without cost-sharing. Many healthcare leaders applauded ...

Study researchers interviewed 12 primary care physicians in leadership positions and other primary care experts. They also held focus groups with 17 frontline primary care providers who haven’t ...

This week, health data platform Arcadia acquired CareJourney, a health analytics firm designed to facilitate participation in value-based care contracts. The deal combines Arcadia’s data ...

As healthcare data analytics and technology advances, precision medicine will become the norm. However, at this point, it’s rarely found in day-to-day primary care, where it could make a ...

Novavax’s alliance with Sanofi came at an opportune time for the beleaguered vaccine developer. Its protein-based Covid-19 vaccine never reached the revenue highs achieved by the messenger RNA ...